IAS 2023, the 12th IAS Conference on HIV Science, will take place in Brisbane, Australia, and virtually, from 23 to 26 July 2023. IAS 2023, being held at the Brisbane Convention and Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.
The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.
Roche is proud to partner with key stakeholders such as The Global Fund and PEPFAR, to meet the UNAIDS HIV 95:95:95 goals stating that by 2030, 95% of all people living with HIV will know their HIV status, 95% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy will have durable viral suppression.
Our portfolio of products will help meet the first and the third 95. Our molecular based test for diagnosis is used to determine the HIV status of babies born to HIV positive mothers. The test also meets the US guidelines for monitoring patients on Pre Exposure Prophylaxis (PrEP).
Roche continues to focus on solutions to make testing available to everyone, regardless of location. To enable greater access to HIV-1 viral load testing, an innovative device was developed to allow for reliable plasma viral load testing, without the need for phlebotomy, centrifugation, or refrigerated sample transportation.